Blood-Based Kinase Assessments in Alzheimer’s Disease

Blood-Based Kinase Assessments in Alzheimer’s Disease

Alzheimer’s disease (AD) is marked by memory disturbances followed by aphasia, apraxia and agnosia. Brain lesions include the accumulation of the amyloid peptide in extracellular plaques, neurofibrillary tangles with abnormally phosphorylated tau protein and synaptic and neuronal loss. New findings...

Full description

Bibliographic Details
Main Authors: Jacques Hugon, François Mouton-Liger, Emmanuel Cognat, Julien Dumurgier, Claire Paquet
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer
kinase
blood
biomarkers
diagnosis
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2018.00338/full

Internet

https://www.frontiersin.org/article/10.3389/fnagi.2018.00338/full

Similar Items